Log | Progress In Mind

Log Type	Authored on	Log Message	Log Node	Authored by
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter Test sent to:nifi@lundbeck.com, wanderson@agenciaamais.com.br, wandersonawlis@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualização contínua em Psiquiatria e Neurologia	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен

Log Type	Authored on	Log Message	Log Node	Authored by
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/equil%C3%ADbrio-vs-burnout-durante-covid-19	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter clicked	Tue, 11/08/2022 - 12:04	Clicked https://brazil.progress.im/pt-br/content/novos-medicamentos-com-anticorpos-monoclonais-t%C3%AAm-como-alvo-cgrp-e-seus-receptores	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter sent	Tue, 11/08/2022 - 12:04	Newsletter Test sent to:nifi@lundbeck.com, wanderson@agenciaamais.com.br, wandersonawlis@gmail.com	Novos medicamentos têm como alvo a CGRP e seus receptores	Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	Atualização contínua em Psiquiatria e Neurologia	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened	É Amanhã! Convite Lundbeck Webinar Internacional	Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
OWA Status	Wed, 10/12/2022 - 13:23	Updating trust level from 1 to 2		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен
Newsletter opened	Wed, 10/12/2022 - 13:23	Opened		Анонимен
Newsletter subscribed	Wed, 10/12/2022 - 13:23	Newsletter subscribed - Progress in Mind SEA		Анонимен
User created	Wed, 10/12/2022 - 13:23	User created		Анонимен

Patrocinado por

Progress in Mind Brazil

INSCRIÇÃO NEWSLETTER